FT : Warren Buffett versus the hedge funds

Warren Buffett versus the hedge funds

Investors locked in to lower expectations and declining returns

With three years to go, Warren Buffett is comfortably winning his charity bet that a low-cost index tracker would trounce a portfolio of hedge funds over ten years.
Returns from the S&P 500 index fund is beating a portfolio of funds assembled by hedge fund manager Protégé Partners by 63.5 per cent to 19.6 per cent, according to a slide Mr Buffett presented at Berkshire Hathaway’s annual meeting at the weekend.

“The hedge fund managers have done very well over that period,” Mr Buffett said, noting that, on a notional $1bn portfolio, they would have made $20m in management fees “just for coming to the office. The investors in the hedge funds have paid a very big price.”
So why is money still pouring into the hedge fund industry? The answer is that investors do not think of hedge funds as an alternative to stocks, but more often now as an alternative to bonds. Mr Buffett’s comparison is no longer a fair one — and the consequence is that the industry’s meagre returns will not improve any time soon.
The latest big name investor to tout hedge funds as an alternative to bonds is Ben Inker, co-head of asset allocation at GMO in Boston.
GMO despairs of finding value in fixed income, now that even the longest dated government bonds yield less than expected inflation in Europe, Japan and UK, and barely match inflation in the US. With yields so low and prices so high, bonds no longer fit the bill as the low-risk cushion in an investment portfolio. Conservative hedge funds are a “superior anchor” for a portfolio, Mr Inker wrote.
For an industry in something of an existential crisis after years of weak returns, this is not a particularly edifying justification for its existence: “Why buy hedge funds? Because everything else sucks.”
Nonetheless, another $18bn flowed into hedge funds globally in the first quarter of 2015, according to research group HFR, taking the industry’s total assets to $2.94tn. This despite investors telling surveys that hedge fund returns have missed expectations almost every year since the financial crisis.
With a few exceptions, notably Californian pension fund Calpers, which axed its allocation to hedge funds, investors have responded instead by lowering expectations.
This makes sense if they are thinking about hedge funds as an alternative to bonds, where the outlook for future returns is poor to downright scary.
The phenomenon has an interesting mirror in the retail investment space, and the rise of so-called “unconstrained” bond funds, which are being marketed as an alternative to traditional fixed income funds whose value may be dented by rising interest rates. These mutual funds give managers wide flexibility to make bets, including negative bets, across the financial markets, making them, in effect, mini-hedge funds.
The marketing pitch of the hedge fund industry urges investors to look through the current malaise and promises that absolute return strategies will come into their own when equity markets stumble and rising interest rates roil the bond market. Commercial real estate and infrastructure may be more obvious substitutes for bonds, since they typically yield cash from rents and fees, but these are illiquid assets that are much harder to access than hedge funds.
Hedge funds seem to be becoming more “bond-like”. An intriguing piece from JPMorgan last week outlined the declining volatility of returns at the average hedge fund.
At 3.2 per cent, the rolling average three-year volatility of the HFRI and Credit Suisse Tremont hedge fund indices has fallen to the same level as that of the Barclays Aggregate index of the US bond market.
What might explain such a development? Certainly the increasing institutionalisation of the industry. Hedge funds cater now largely to institutional investors, such as pension funds, whose officers all have nervous trustees to answer to, and they win or lose business at the whim of consultants, who are notoriously intolerant of periods of poor performance.
And then there is the question of hedge funds as a fixed income substitute. Hedge fund managers respond to supply and demand just like everybody else. If investors are looking to them to provide the kind of conservative portfolio cushion that used to be provided by bonds, then they are likely to invest more conservatively in order to win and to keep business.
The result is that hedge funds and their investors are locked in a downward spiral of lower expectations and declining returns. Mr Buffett’s bet looks safe.

>>> Tyson Foods on call --> Stock opened +1.4%

Tyson Foods on call

Domestic demand for protein remains strong. Consumers are spending more on food (less on fuel).
  • Prepared food segment seeing top and bottom line growth
  • Co saw $20 mln operating income impact from West Cost ports/Avian Flu; port impact should abate. Turkey and table eggs impacted by Avian (bird) flu; loss of exports, leg quarters
  • Have seen bottom in beef supply cycle
  • Pork demand has been soft
  • Sees 10% EPS growth next year

>>> Tyson Foods beats by $0.03, misses on revs; guides FY15 revs below consensus

Tyson Foods beats by $0.03, misses on revs; guides FY15 revs below consensus

Reports Q2 (Mar) earnings of $0.75 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.72; revenues rose 10.5% year/year to $9.98 bln vs the $10.09 bln consensus. "Our fiscal second quarter is seasonally challenging, but we came in above our projections due to strong performances by our Prepared Foods and Chicken segments."
  • Co issues guidance for FY15, sees FY15 revs of approx $41 bln vs. $42.18 bln Capital IQ Consensus Estimate.
  • "In fiscal 2015, we expect domestic protein production (chicken, beef, pork and turkey) to increase approximately 2% from fiscal 2014 levels. Grain supplies are expected to increase in fiscal 2015, which should result in lower input costs as well as decreased costs for cattle and hog producers. The following is a summary outlook for each of our segments, as well as an outlook on sales, capital expenditures, net interest expense, liquidity and share repurchases. Our accounting cycle results in a 53-week year in fiscal 2015 as compared to a 52-week year in fiscal 2014. Accordingly, the outlook is based on a 52-week year."

--> Conf call : Tyson Foods reaffirmed FY15 EPS $3.30-3.40 vs $3.38 Capital IQ Consensus


Tyson Foods (TSN 40.50) is trading lower this morning after reporting first quarter results and issuing guidance for the full year.

The company reported second quarter adjusted earnings of $0.75 per share, beating expectations (year/year adjusted earnings rose 25%). On the top line, revenues rose 10.5% year/year to $9.98 billion, which fell just a little short of expectations.

Overall, the company came in above expectations on strong performances in its Prepared Foods and Chicken segments.

During the quarter, chicken, pork and prepared foods margins all improved year/year. Chicken prices were flat year/year, however, feed ingredient costs came in lower, helping boost operating income.

Meanwhile, margins for beef and international weakened. Sales volume fell in both segment. Average sales prices fell in the brief segment, while average sales prices rose in its international segment.

Overall, beef and chicken made up about 68% of total company sales (beef 40%, chicken 28%). Prepared foods made up 18% and pork made up 12%. The company said, "Our fiscal second quarter is seasonally challenging, but we came in above our projections due to strong performances by our Prepared Foods and Chicken segments."

Looking ahead, Tyson expects to see revenue in fiscal year 2015 of approximately $41 billion, which falls short of expectations.

"In fiscal 2015, we expect domestic protein production (chicken, beef, pork and turkey) to increase approximately 2% from fiscal 2014 levels. Grain supplies are expected to increase in fiscal 2015, which should result in lower input costs as well as decreased costs for cattle and hog producers. The following is a summary outlook for each of our segments, as well as an outlook on sales, capital expenditures, net interest expense, liquidity and share repurchases. Our accounting cycle results in a 53-week year in fiscal 2015 as compared to a 52-week year in fiscal 2014. Accordingly, the outlook is based on a 52-week year."

>>> US Gapping down

Gapping down In reaction to disappointing earnings/guidance: DCI -2%, KOS -1.9%, MGM -1.9%, BWP -1.7%, HYH -1.7%, WBK -1.3%, SYY -1.3%, ARCC -1.2%, NMM -0.8%, D -0.6%, HSIC -0.5%

M&A news: SYT -6.8% (pulling back following M&A speculation on Friday)

Other news: NBG -4.8% (little progress in Greece negotiations over the wkend), EMES -4.5% (CFO departs for personal reasons), VALE -2.1% (modest pull back following last week's advances), ARP -1.8% (files for $600 mln mixed securities shelf offering), CNHI -1.6% (small pull back following recent strength last week), ADPT -1.6% (proposed common stock offering of 2.1 mln shares), STM -1% (cont weakness)

Analyst comments: ANF -2.1% (initiated with a Underperform at RBC Capital Mkts), SCTY -1.2% (downgraded to Neutral from Outperform at Robert W. Baird), BUD -0.5% (downgraded to Underperform from Outperform at Credit Agricole)

>>> US Gapping up

Gapping up In reaction to strong earnings/guidance: ARRY +13.9%, SCOK +6.9%, BSFT +4.9%, ON +4.8%, CTSH +4.4%, PETS +3.3%, DO +2.5%, RLGY +2.5%, CMCSA +1.7%, BRK.B +1.1%, EXAS +1%, CVC +0.5%

M&A news: CYNI +24.9% (entered into a definitive agreement to be acquired by Ciena (CIEN) for approximately $4.75 per share of Cyan common stock), FRM +19.1% (has received a written non-binding indication of interest from a strategic acquiror for a transaction in which all Furmanite stockholders would receive cash for their shares, at a substantial premium to current market prices), NYT +4.4% (Michael Bloomberg may bid $5 bln for NYT, according to Fox Business)

Other news: IMNP +4.9% (Immune Pharma and STC Biologics announce strategic partnership to accelerate development of NanomAbs), BLRX +4.7% (successful completion dose escalation stage in its ongoing Phase 2 study of BL-8040), NETE +3.4% (entered into a Securities Purchase Agreement to offer and sell 5,500 shares of newly-issued Series A Convertible Preferred Stock having an aggregate offering price of $5.5 mln; also announced 2 other financings), ARRS +2.8% (Arris and Tivo announce partnership on an integration of TiVo software and cloud-based services with ARRIS set-top boxes), ALU +2.6% (in symp with NOK, which was upgraded today), TIVO +2.1% (Arris and Tivo announce partnership on an integration of TiVo software and cloud-based services with ARRIS set-top boxes), CTIC +1.7% ( Baxalta Incorporated discloses 8.7% passive stake in 13G filing), MDR +1.1% (received a large contract amendment from Al-Khafji Joint Operations for a platform in the Hout field), TSLA +0.9% (Edison International (EIX) teams up with Tesla for battery storage projects), WYNN +0.7% (Macau Gaming Inspection and Coordination Bureau reports April gross gaming rev -39% YoY)

Analyst comments: CBYL +9% (initiated with a Outperform at Wedbush; tgt $21), QTM +3.4% (upgraded to Outperform from Market Perform at Northland Capital), WLL +3% (upgraded to Overweight from Equal-Weight at Morgan Stanley), NOK +2.5% (upgraded to Buy at Kepler), JD +2% (target raised to $44 at Oppenheimer), WETF +1.5% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), TWTR +1.4% (upgraded to Hold from Sell at Stifel), LNKD +1.4% (upgraded to Buy from Hold at Argus), WFM +1.1% (target raised to $65 at Oppenheimer), AMZN +0.8% (target raised to $525 at Oppenheimer)

>>> PartnerRe Reaffirms Commitment to Merger with AXIS Capitalm, rejects $130/sh

PartnerRe Reaffirms Commitment to Merger with AXIS Capitalm, rejects $130/share proposal From Exor 

- PartnerRe has rejected the unsolicited proposal by EXOR S.p.A. to acquire PartnerRe at a price of $130 per share. The Company further reaffirmed its commitment to the planned merger with AXIS Capital Holdings Limited (AXIS Capital) (NYSE:AXS) and announced enhanced merger terms that allow PartnerRe to pay a one-time special dividend of $11.50 per common share to PartnerRe common shareholders prior to the closing of the amalgamation agreement between PartnerRe and AXIS Capital.

- The PartnerRe Board noted that throughout the course of negotiations, EXOR maintained its $130 per share proposal, and indicated that due diligence on PartnerRe would be confirmatory only and that there would be no price improvement. Despite numerous attempts by the PartnerRe Board to negotiate on price, EXOR stated that $130 per share was its best and only offer.

- The PartnerRe Board concluded from these negotiations and analysis that the EXOR proposal does not properly or adequately value PartnerRe, as it does not fully recognize the strength of its balance sheet and the value of its franchise Further, the PartnerRe Board determined that superior value is created through the enhanced merger terms with AXIS Capital, and the substantial long-term value potential of the combination with AXIS Capital. - Source TradeTheNews.com